DexCom Inc (DXCM) — Capital Reinvestment Ratio
Latest as of March 2026:
0.15x
DexCom Inc (DXCM) has a Capital Reinvestment Ratio of 0.15x as of March 2026, meaning it reinvests 0% of its operating cash flow ($525.60 Million) in capital expenditures ($76.60 Million). See how much free cash does DexCom Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.15x
Capex / Operating Cash Flow
Operating Cash Flow
$525.60 Million
USD
Capital Expenditures
$76.60 Million
USD
Data as of
Mar 2026
Most recent filing
DexCom Inc Capital Reinvestment Ratio (2013–2025)
This chart tracks DexCom Inc's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for DexCom Inc (2013–2025)
Year-by-year Capital Reinvestment Ratio for DexCom Inc from 2013 to 2025. For live market cap and broader valuation context, see market cap of DexCom Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | $1.44 Billion | $363.50 Million | ▼ -30.4% |
| 2024 | 0.36x | $989.50 Million | $358.80 Million | ▲ +14.7% |
| 2023 | 0.32x | $748.50 Million | $236.60 Million | ▼ -42.0% |
| 2022 | 0.54x | $669.50 Million | $364.80 Million | ▼ -38.0% |
| 2021 | 0.88x | $442.50 Million | $389.20 Million | ▲ +110.2% |
| 2020 | 0.42x | $475.60 Million | $199.00 Million | ▼ -26.9% |
| 2019 | 0.57x | $314.50 Million | $180.00 Million | ▲ +5.1% |
| 2018 | 0.54x | $123.20 Million | $67.10 Million | ▼ -24.1% |
| 2017 | 0.72x | $92.00 Million | $66.00 Million | ▼ -27.6% |
| 2016 | 0.99x | $56.20 Million | $55.70 Million | ▲ +45.8% |
| 2015 | 0.68x | $49.00 Million | $33.30 Million | ▼ -1.0% |
| 2014 | 0.69x | $23.60 Million | $16.20 Million | ▼ -79.1% |
| 2013 | 3.29x | $2.40 Million | $7.90 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow